LGT Fund Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.26M Hold
50,850
0.22% 105
2026
Q1
$3.65M Buy
+50,850
New +$3.92M 0.16% 134
2024
Q2
Sell
-9,000
Closed -$718K 201
2024
Q1
$718K Hold
9,000
0.3% 81
2023
Q4
$711K Hold
9,000
0.31% 79
2023
Q3
$627K Hold
9,000
0.3% 74
2023
Q2
$622K Buy
9,000
+1,500
+20% +$107K 0.29% 73
2023
Q1
$557K Hold
7,500
0.24% 81
2022
Q4
$699K Hold
7,500
0.3% 67
2022
Q3
$715K Sell
7,500
-12,216
-62% -$1.21M 0.34% 66
2022
Q2
$1.83M Buy
19,716
+974
+5% +$95.1K 0.27% 98
2022
Q1
$1.9M Buy
18,742
+11,242
+150% +$1.18M 0.25% 104
2021
Q4
$774K Buy
+7,500
New +$693K 0.22% 75

Other funds holding CVS

LGT Fund Management's CVS Position: Q2 2026 in Review

LGT Fund Management held its CVS Health (CVS) position steady in Q2 2026 at 50,850 shares worth $5.26M. The position accounts for 0.22% of the portfolio, ranked #105.

LGT Fund Management first reported a position in CVS in Q4 2021 and has held it in 12 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • LGT Fund Management held 50,850 shares of CVS Health worth $5.26M as of Q2 2026.
  • LGT Fund Management left its CVS Health share count unchanged in Q2 2026.
  • CVS Health made up 0.22% of LGT Fund Management's portfolio in Q2 2026, its #105 holding.
  • LGT Fund Management first reported a position in CVS Health in Q4 2021 and has held it in 12 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on LGT Fund Management's 13F filing for Q2 2026, filed 10 Aug 2026.